Skip to main content

Seagen Inc.

SGENDelisted Dec 14, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001060736

Seagen Inc. was delisted on Dec 14, 2023; its insiders filed their last Form 4 on Dec 18, 2023; 614 institutions reported holding it in 13F filings for Q3 2023, worth $36.3B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Seagen Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Seagen Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Seagen Inc.
NameTitleLast reported holdingLast filingFilings, past year
Baker JulianDirector, Other: Former 10% Owner0IndirectDec 18, 20230
Baker FelixDirector, Other: Former 10% Owner0IndirectDec 18, 20230
Baker Bros. Advisors LPDirector, Other: Former 10% Owner0IndirectDec 18, 20230
Baker Brothers Life Sciences LPDirector, Other: Former 10% Owner0IndirectDec 18, 20230
667, L.P.Director, Other: Former 10% Owner0IndirectDec 18, 20230
Baker Bros. Advisors (GP) LLCDirector, Other: Former 10% Owner0IndirectDec 18, 20230
Love Ted WDirector0Dec 15, 20230
Gryska David WDirector0Dec 15, 20230
Welch Daniel GDirector0IndirectDec 15, 20230
Simpson Todd EChief Financial Officer0Dec 15, 20230
Liu Jean IChief Legal Officer0Dec 15, 20230
Simonian Nancy ADirector0Dec 15, 20230
Himes Vaughn BChief Technical Officer0IndirectDec 15, 20230
Epstein David RCEO0Dec 15, 20230
Orwin John ADirector0Dec 15, 20230
Seth AlpnaDirector0Dec 15, 20230
Dansey Roger DPresident, R&D & CMO0Dec 15, 20230
Romp Charles REVP, Commercial U.S.0Dec 15, 20230
Swain Sandra MDirector0Dec 15, 20230
Siegall Clay BPresident & CEO666,060May 13, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 22, 2022 (view filing)Jun 175 daysHimes Vaughn BChief Technical OfficerSSale−1.13K$160.00−$181.4K−0.9%119.5K after
Jun 30, 2022 (view filing)Jun 282 daysDansey Roger DChief Medical OfficerSSale−34.6K$180.00−$6.23M−35.8%62.1K after5 lots
Jul 7, 2022 (view filing)Jul 52 daysRomp Charles REVP, CommercialSSale−712$179.46−$127.8K−1.4%48.8K after
Aug 17, 2022 (view filing)Aug 161 dayDansey Roger DInterim CEO & CMOSSale−4.25K$170.22−$724.1K−4.0%102.6K after2 lots
Aug 17, 2022 (view filing)Aug 161 dayHimes Vaughn BChief Technical OfficerSSale−1.53K$170.22−$259.9K−2.1%70.8K after2 lots
Aug 17, 2022 (view filing)Aug 161 dayLiu Jean IChief Legal OfficerSSale−1.64K$170.22−$279.0K−1.8%88.0K after2 lots
Aug 17, 2022 (view filing)Aug 161 dayRomp Charles REVP, CommercialSSale−1.76K$170.22−$300.4K−2.8%60.7K after2 lots
Aug 17, 2022 (view filing)Aug 161 daySimpson Todd EChief Financial OfficerSSale−1.97K$170.22−$334.8K−1.4%141.4K after2 lots
Sep 1, 2022 (view filing)Aug 311 dayLiu Jean IChief Legal OfficerSSale−3.65K$154.41−$563.3K−4.1%84.4K after2 lots
Sep 1, 2022 (view filing)Aug 311 dayDansey Roger DInterim CEO & CMOSSale−5.02K$154.41−$775.0K−4.9%97.5K after3 lots
Sep 1, 2022 (view filing)Aug 311 dayRomp Charles REVP, CommercialSSale−1.13K$154.41−$174.9K−1.9%59.6K after2 lots
Sep 1, 2022 (view filing)Aug 311 dayHimes Vaughn BChief Technical OfficerSSale−3.58K$154.41−$553.4K−5.1%67.2K after2 lots
Sep 1, 2022 (view filing)Aug 311 daySimpson Todd EChief Financial OfficerSSale−4.19K$154.41−$646.4K−3.0%137.2K after2 lots
Oct 19, 2022 (view filing)Oct 172 daysDansey Roger DInterim CEO & CMOSSale−10.0K$135.00−$1.35M−9.3%97.5K after3 lots
Nov 15, 2022 (view filing)Nov 114 daysGryska David WDirectorSSale−7.50K$129.10−$968.3K−15.7%40.3K after
Nov 18, 2022 (view filing)Nov 171 dayLiu Jean IChief Legal OfficerSSale−8.33K$131.05−$1.09M−8.9%85.7K after
Dec 16, 2022 (view filing)Dec 142 daysDansey Roger DPresident, Research and DeveloSSale−10.0K$135.00−$1.35M−9.3%97.5K after2 lots
Dec 21, 2022 (view filing)Dec 201 dayRomp Charles REVP, Commercial U.S.SSale−1.13K$127.63−$144.1K−1.9%58.5K after
Jan 6, 2023 (view filing)Jan 4-52 daysLiu Jean IChief Legal OfficerSSale−5.00K$135.00−$675.0K−5.5%85.7K after2 lots
Jan 6, 2023 (view filing)Jan 4-52 daysDansey Roger DPresident R&D & CMOSSale−10.0K$135.00−$1.35M−9.3%97.5K after2 lots
Jan 19, 2023 (view filing)Jan 172 daysLiu Jean IChief Legal OfficerSSale−578$130.71−$75.6K−0.7%85.1K after
Jan 26, 2023 (view filing)Jan 242 daysLiu Jean IChief Legal OfficerSSale−5.00K$135.03−$675.1K−5.5%85.1K after
Jan 26, 2023 (view filing)Jan 242 daysDansey Roger DPresident, R&D & CMOSSale−10.0K$135.00−$1.35M−9.3%97.5K after
Feb 3, 2023 (view filing)Feb 21 dayDansey Roger DPresident, R&D & CMOSSale−783$138.52−$108.5K−0.8%96.9K after
Feb 17, 2023 (view filing)Feb 152 daysDansey Roger DPresident, R&D & CMOSSale−10.0K$140.64−$1.41M−9.4%96.9K after3 lots
Feb 21, 2023 (view filing)Feb 165 daysLiu Jean IChief Legal OfficerSSale−5.00K$155.00−$775.0K−5.5%85.1K after
Feb 21, 2023 (view filing)Feb 165 daysSimpson Todd EChief Financial OfficerSSale−39.9K$160.00−$6.39M−22.6%137.2K after
Feb 28, 2023 (view filing)Feb 271 daySimpson Todd EChief Financial OfficerSSale−20.0K$182.53−$3.65M−14.6%117.2K after
Mar 3, 2023 (view filing)Mar 21 dayHimes Vaughn BChief Technical OfficerSSale−16.2K$177.21−$2.87M−19.4%67.3K after2 lots
Mar 10, 2023 (view filing)Mar 91 daySimpson Todd EChief Financial OfficerSSale−42.8K$176.61−$7.56M−26.7%117.2K after3 lots
Mar 16, 2023 (view filing)Mar 13-143 daysLateWelch Daniel GDirectorSSale−17.9K$200.35−$3.59M−71.3%7.22K after9 lots
Mar 16, 2023 (view filing)Mar 13-143 daysLateWelch Daniel GDirectorSSale−9.48K$200.35−$1.90M−28.1%24.3K after4 lots
Mar 17, 2023 (view filing)Mar 152 daysDansey Roger DPresident, R&D & CMOSSale−10.0K$199.81−$2.00M−9.4%96.9K after
Mar 17, 2023 (view filing)Mar 152 daysWelch Daniel GDirectorSSale−2.36K$200.05−$471.5K−25.5%6.90K after2 lots
Mar 17, 2023 (view filing)Mar 152 daysWelch Daniel GDirectorSSale−1.25K$200.05−$249.3K−5.1%23.1K after
Mar 17, 2023 (view filing)Mar 161 dayLiu Jean IChief Legal OfficerSSale−5.00K$199.90−$999.5K−5.5%85.1K after
Apr 5, 2023 (view filing)Apr 32 daysWelch Daniel GDirectorSSale−20.3K$201.61−$4.09M−83.0%4.15K afterFrom original9 lots10b5-1
Apr 5, 2023 (view filing)Apr 32 daysWelch Daniel GDirectorSSale−10.7K$201.61−$2.16M−46.5%12.3K afterFrom original3 lots10b5-1
Apr 7, 2023 (view filing)Apr 61 daySimpson Todd EChief Financial OfficerSSale−243$205.86−$50.0K−0.2%118.9K afterFrom original10b5-1
Apr 7, 2023 (view filing)Apr 61 dayHimes Vaughn BChief Technical OfficerSSale−243$205.86−$50.0K−0.4%68.8K afterFrom original10b5-1
Apr 7, 2023 (view filing)Apr 61 dayRomp Charles REVP, Commercial U.S.SSale−133$205.86−$27.4K−0.2%60.1K afterFrom original10b5-1
Apr 7, 2023 (view filing)Apr 61 dayLiu Jean IChief Legal OfficerSSale−174$205.86−$35.8K−0.2%86.8K afterFrom original10b5-1
Apr 7, 2023 (view filing)Apr 61 dayDansey Roger DPresident, R&D & CMOSSale−333$205.86−$68.6K−0.3%99.4K afterFrom original10b5-1
Apr 12, 2023 (view filing)Apr 102 daysSimpson Todd EChief Financial OfficerSSale−55.3K$204.58−$11.3M−31.8%118.9K after2 lots10b5-1
Apr 19, 2023 (view filing)Apr 172 daysDansey Roger DPresident, R&D & CMOSSale−10.0K$205.95−$2.06M−9.1%99.4K after10b5-1
Apr 19, 2023 (view filing)Apr 172 daysLiu Jean IChief Legal OfficerSSale−5.00K$205.86−$1.03M−5.4%86.8K after10b5-1
May 3, 2023 (view filing)May 1-22 daysWelch Daniel GDirectorSSale−16.3K$200.07−$3.26M−72.3%6.25K after7 lots10b5-1
May 3, 2023 (view filing)May 1-22 daysWelch Daniel GDirectorSSale−10.7K$200.07−$2.15M−46.5%12.3K after2 lots10b5-1
May 16, 2023 (view filing)May 151 dayWelch Daniel GDirectorSSale−1.86K$200.02−$372.8K−23.0%6.25K after10b5-1
May 18, 2023 (view filing)May 162 daysRomp Charles REVP, Commercial U.S.SSale−349$189.86−$66.3K−0.6%59.8K after10b5-1